1Fischer BM, Mortensen J, Hojgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review [J]. Lancet Oncol, 2001,2:659-666. 被引量：1
2Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer [J]. Ann Intern Med, 2003,139: 879-892. 被引量：1
3Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules [J]. J Clin Oncol, 1998, 16: 1075-1084. 被引量：1
4Verboom P, van Tinteren H, Hoekstra OS, et al. Costeffectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study [J]. Eur J Nucl Med Mol Imaging,2003,30:1444-1449. 被引量：1
8Muhammad Wasif Saif, Ifigenia Tzannou, Nektaria Makrilia,Kostas Syrigos. Role and Cost Effectiveness of PET/CT in Management of Patients with Cancer. Yale Journal of Biology And Medicine ,2010,83:53-65. 被引量：1
10Gugiani A, Grimaldi A, Rossetti C, Economic analyses on the use of positron emission tomograptly for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Q J Nucl Med Mol Imaging, 2004, 48(1): 49-61. 被引量：1
